1 Min Read
Nov 16 (Reuters) - Delmar Pharmaceuticals Inc
* Delmar Pharmaceuticals Inc interim CEO Saiid Zarrabian reports purchase of 60,900 shares of co's common stock on nov 14 - SEC Filing Source text: (bit.ly/2hydYIN) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.